KT
NASDAQ · KTTAW
Pasithea Therapeutics Corp.
Healthcare · Biotechnology
$0.00
Down-$0.00 (-6.67%)
Updated Nov 5, 2026, 1:37 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 275.36K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.00 – $0.02
- Volume
- 25.6K
- Avg. volume
- 42.59K
Price performance · KTTAW
KTTAW price history
1M range · 0 trading sessions · Daily adjusted prices
KTTAW does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest KTTAW news
The latest Smart Investors Daily articles mentioning KTTAW.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…
